Haryana Well being Minister Anil Vij on Friday administered a trial dose of coronavirus vaccine candidate Covaxin, at a hospital in Ambala. He had provided to be the primary volunteer for the third part trial of Covaxin, which began within the state at this time. Covaxin is being developed indigenously by Bharat Biotech in collaboration with the Indian Council of Medical Analysis (ICMR).
Vij, who’s an MLA from Ambala Cantt, had on Wednesday mentioned the third part of trial of Covaxin will start within the state on November 20. Taking to twitter, Ani Vij mentioned: “I can be administered a trial dose of Coronavirus vaccine #Covaxin a Bharat Biotech product Tomorrow at 11 am at Civil hospital, Ambala Cantt below the skilled supervision of a crew of medical doctors from PGI Rohtak and Well being Division. I’ve volunteered to take the trial dose.”
He had provided to be the primary volunteer for the third part trial of Covaxin, which began within the state at this time. pic.twitter.com/xKuXWLeFAB
— ANI (@ANI) November 20, 2020
Final month, Covaxin mentioned it had efficiently accomplished interim evaluation of Section 1 and a pair of trials and is initiating Section 3 trials.
Bharat Biotech had on Monday mentioned the Section 3 trial of Covaxin will contain 26,000 volunteers throughout 25 centres in India and is being performed in partnership with the ICMR. It’s the largest scientific trial performed for a COVID-19 vaccine in India.
That is India’s first Section 3 efficacy research for a COVID-19 vaccine, and the biggest Section 3 efficacy trial ever performed.